目的:本调查的主要目的是设计一种移动应用程序,用于癌症相关不适的自我管理,以提高患者的整体健康为总体目标。与传统的随访程序相比,使用自我管理应用程序会改善生活质量吗?
方法:模块是在使用Delphi技术的肿瘤疼痛专家的协作专业知识下精心设计的。使用Cronbach'sα评估咨询的可靠性。开发应用程序后,进行了一项前瞻性随机对照研究,以评估该应用对参与者生活质量的影响.试验组使用该应用程序;对照组接受了后续电话咨询。在基线和4周干预期后进行生活质量评估。
结果:经过两轮Delphi专家咨询,疼痛卫士的功能模块被确定为包括五个功能模块,包括疼痛自我测量(患者疼痛的实时动态记录),患者提醒(疼痛处置爆发的提醒,药物,andreview),上传检查报告,在线咨询,健康教育,等功能模块。克朗巴赫的α为0.81。总的来说,96例患者(包括食道,胃,结直肠,鼻咽,肺,胰腺,乳房,卵巢,子宫,骨头,胸廓,膀胱,子宫颈,软组织肉瘤,纵隔,和淋巴瘤)患有癌症疼痛的患者分为试验组和对照组。两组之间的基本信息和基线生活质量没有显着差异。经过4周的干预,试验组的生活质量显著高于对照组.患者对应用程序的满意度很高(93.7%)。
结论:在治疗癌症相关不适的应用开发中遇到的主要障碍在于主题的敏感性,可能导致患者担心疼痛管理的应用程序使用。因此,对用户偏好和预期的细致关注势在必行,需要创建以用户友好性和医疗功效为特征的应用程序。
背景:中国临床试验注册ChiCTR1800016066;http://www.chictr.org.cn/showproj.aspx?proj=27153。注册日期:2018-05-09。
OBJECTIVE: The primary objective of this investigation was to devise a mobile application for self-management of cancer-related discomfort, with the overarching goal of enhancing patients\' overall well-being. Would the utilization of the self-management application result in an amelioration of life quality compared to conventional follow-up procedures?
METHODS: Modules were meticulously devised with the collaborative expertise of oncology pain specialists employing the Delphi technique. Reliability of the consultation was assessed using Cronbach\'s α. After developing the app, a prospective randomized controlled study was conducted to evaluate the app\'s effect on participants\' quality of life. The trial group used the app; the control group received a follow-up
telephone consultation. Assessments of quality of life were conducted both at baseline and following a 4-week intervention period.
RESULTS: After two rounds of Delphi expert consultation, the functional modules of Pain Guardian were determined to include five functional modules, including pain self-measurement (real-time dynamic recording of pain by patients), patient reminders (reminders of outbreaks of pain disposal, medication, and review), uploading of examination reports, online consultation, health education, and other functional modules. Cronbach\'s α was 0.81. Overall, 96 patients (including esophageal, gastric, colorectal, nasopharyngeal, pulmonary, pancreatic, breast, ovarian, uterine, bone, thoracic, bladder, cervical, soft tissue sarcoma, mediastinal, and lymphoma) with cancer pain were divided into the trial and control groups. There were no significant differences in basic information and quality of life at baseline between groups. After 4 weeks of intervention, quality of life was significantly higher in the trial group than in the control group. Patients\' satisfaction with the app was high (93.7%).
CONCLUSIONS: The primary obstacle encountered in the development of applications for managing cancer-related discomfort lies in the sensitive nature of the subject matter, potentially leading to patient apprehension regarding application usage for pain management. Consequently, meticulous attention to user preferences and anticipations is imperative, necessitating the creation of an application characterized by user-friendliness and medical efficacy.
BACKGROUND: Chinese Clinical Trials Registry ChiCTR1800016066; http://www.chictr.org.cn/showproj.aspx?proj=27153 . Date of Registration: 2018-05-09.